Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biomerica Secures European Patent Approvals for inFoods® Technology Targeting Multi-Billion-Dollar Gastrointestinal Markets Quiver Quantitative, Inc. - Thu Nov 21, 5:36PM CST

Biomerica receives European patents for inFoods® technology targeting GERD, Crohn’s Disease, and Ulcerative Colitis, tapping into significant market potential.Quiver AI SummaryBiomerica, Inc. has announced...

BMRA : 0.3235 (-0.25%)
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis GlobeNewswire - Thu Nov 21, 7:19AM CST

BMRA : 0.3235 (-0.25%)
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements GlobeNewswire - Thu Nov 7, 8:09AM CST

BMRA : 0.3235 (-0.25%)
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain GlobeNewswire - Wed Oct 30, 7:19AM CDT

BMRA : 0.3235 (-0.25%)
Biomerica Reports First Quarter Fiscal 2025 Financial Results GlobeNewswire - Wed Oct 16, 8:00AM CDT

BMRA : 0.3235 (-0.25%)
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam Globe Newswire - Thu Jul 14, 2022

Simple at-home device to increase sensitivity in breast self examsEarly detection of breast cancer saves livesBreast Cancer accounts for 1 in 3 new cases...

BMRA : 0.3235 (-0.25%)
Biomerica to Participate at BTIG Biotech Conference Globe Newswire - Thu Jun 23, 2022

IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company’s CEO will participate at the 2022 BTIG...

BMRA : 0.3235 (-0.25%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 AccessWire - Mon May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 3.37 (-0.88%)
LPTH : 1.5000 (unch)
RCAT : 7.30 (+14.60%)
IONM : 0.0587 (+30.73%)
PYR : 0.3799 (unch)
OSS : 2.44 (+4.72%)
MODD : 1.94 (-5.83%)
STRN : 1.3400 (+0.75%)
AEYE : 25.24 (+0.94%)
SMFL : 0.0450 (-2.17%)
LFMD : 5.69 (+4.98%)
SURG : 1.8000 (+23.29%)
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™ Globe Newswire - Thu May 12, 2022

- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant...

BMRA : 0.3235 (-0.25%)
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population Globe Newswire - Tue Apr 26, 2022

Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial...

BMRA : 0.3235 (-0.25%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot